Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Intelligent exogenous predictive networks for nonlinear Parkinson's disease model involving delay with effects of immunotherapy.

Created on 24 Oct 2026

Authors

Naveed Ishtiaq Chaudhary, Aqib Mukhtar, Iqra I Chaudhary, Muhammad Asif Zahoor Raja

Published in

Computational biology and chemistry. Volume 126. Issue Pt 2. Pages 109501. Oct 21, 2026. Epub Oct 21, 2026.

Abstract

Artificial intelligence is used to simulate, solve, or approximate the dynamics of complex neurodegenerative diseases through accurate prediction. Parkinson's disease (PD) is a progressive disorder caused by the loss of dopaminergic neurons, leading to motor impairments such as muscle stiffness, tremors, and Bradykinesia. In this study, artificial intelligence-driven nonlinear autoregressive exogenous neural networks (AI-NARX-NN) are applied to the existing mathematical model reflecting the dynamics of innate as well as adaptive immune responses to PD under immunotherapy (IAIR-PDI). The IAIR-PDI model is characterized by a delay differential system of five classes representing the densities of healthy neurons, affected neurons, extracellular alpha-syn, activated microglia, and activated T cells. The performance of the AI-NARX-NN is investigated in scenarios of active immunization, passive immunization, and no treatment in the IAIR-PDI model. In the active immunization case, short antigenic peptide vaccination is given to the patients that mimics alpha-syn to generate antibodies, whereas in the passive immunization case, antibody vaccination is given directly to PD patients. The simulation results, including mean-square-error-based convergence curves, histograms, error correlation, solution plots, and corresponding absolute errors, confirm strong agreement between the AI-NARX-NN predictions and the reference numerical solutions, supporting the accuracy of the proposed scheme for the IAIR-PDI model with different time delays.

PMID:
42913159
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 16
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement